danazol has been researched along with Deficiency, Factor II in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Comp, P; Gralnick, HR; Linardic, C; Williams, S; Wilson, O | 1 |
| Ahmad, M; Al-Mouzan, MI; Sumer, NK; Sumer, T | 1 |
2 other study(ies) available for danazol and Deficiency, Factor II
| Article | Year |
|---|---|
Acquired hypoprothrombinemia: effects of danazol treatment.
Topics: Blood Loss, Surgical; Colonic Polyps; Danazol; Humans; Hypoprothrombinemias; Lupus Coagulation Inhibitor; Lupus Erythematosus, Discoid; Male; Middle Aged; Prothrombin Time | 1996 |
Severe congenital factor X deficiency with intracranial haemorrhage.
Topics: Blood Transfusion; Cerebral Hemorrhage; Child, Preschool; Danazol; Estradiol; Factor X Deficiency; Humans; Hypoprothrombinemias; Male; Partial Thromboplastin Time; Prothrombin Time; Vitamin K | 1986 |